Navigation Links
2009 Science Report on Genetic Disease Released by Cystinosis Research Foundation
Date:3/9/2009

Researchers of the genetic disease Cystinosis report encouraging news. The Cystinosis Research Foundation has published the third edition of its Science Report, which is designed to provide updates on cystinosis research under way and includes new abstracts of the 12 cystinosis grants issued in 2008. Cystinosis is a rare and fatal metabolic genetic disease that afflicts about 2,000 children worldwide. The CRF Science Report is available at www.cystinosisresearch.org

Irvine, CA (PRWEB) March 9, 2009 -- Researchers of the genetic disease Cystinosis report encouraging news. The Cystinosis Research Foundation has published the third edition of its Science Report, which is designed to provide updates on cystinosis research under way and includes new abstracts of the 12 cystinosis grants issued in 2008. Cystinosis is a rare, genetic and slowly fatal metabolic disease that afflicts about 2,000 children worldwide. The CRF Science Report is available at www.cystinosisresearch.org.

The CRF research teams working on a cure for cystinosis continue to report encouraging news. The research undertaken has "significantly changed the course of cystinosis research and we are moving closer to our mission: to find improved cystinosis treatments and a cure for cystinosis," said Nancy Stack, president of CRF.

The Cystinosis Research Foundation was formed in 2003 and has raised $9.3 million, all of which is committed for medical research. The CRF is the largest fund provider of cystinosis research in the world. Currently, the CRF is funding 25 cystinosis research studies, including seven research fellows in six countries. The foundation has $1.2 million available for new research and plans to issue a global call for research proposals and fellowship grants on March 15, 2009. In 2008, the CRF funded 12 studies with grants totaling $1,741,889.

"The advancements achieved so far are the result of the CRF's focused mission and targeted approaches to cystinosis research. This gets research funds directly into the labs of the world's leading cystinosis doctors and scientists so they can complete their important work. This policy has produced a greater understanding of the disease and the first improvement in treatment to come in more than 25 years," she said.

In patients with cystinosis, the amino acid cystine accumulates in the tissue due to the inability of the body to transport cystine out of the cell. This causes development of crystals, resulting in early cell death.

The genetic disease slowly destroys every organ in the body, including the liver, kidneys, eyes, muscles, thyroid and brain. There is a medicine that prolongs the children's lives, but there is no cure. Almost all sufferers succumb before 40 years old.

Today, with the support of CRF's friends and community the foundation has significantly changed the course of cystinosis research and this genetic disease. CRF's funding efforts have allowed talented doctors and leading cystinosis researchers into initiate novel research studies and advance their cystinosis research efforts. For more information on the organization and its science report call CRF at 949-22-7610 or visit the site.

###

Read the full story at http://www.prweb.com/releases/2009/03/prweb2208574.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Americans United for Life: Rescinding of Conscience Protections for Healthcare Providers Outrageous
2. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM)
3. New Book Exposes Junk Science, Conflicts of Interest, Disease Guidelines Affecting Millions
4. HIV Experts Propose New Approach to Eradicate HIV in Latest Issue of Science
5. Daisyphone, virtual cocoon and smart house at London science conference
6. Crossflo Health Information Exchange Project Presented at HP Health and Life Sciences Symposium
7. Sigma-tau HealthScience Launches www.GlycoCarn.com
8. SpectraScience Receives FDA Clearance for Manufacturing Facility
9. Cardiac Science Schedules Fourth Quarter Earnings Release and Announces Conference Call
10. Bishops Pro-Life Official Gravely Concerned Over Threat to HHS Conscience Protection Regulation
11. Bill Would Require Nutrition Info on Chain Restaurant Menus and Menu Boards, Says Center for Science in the Public Interest -- News Conference on Tuesday, March 3 in Annapolis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, and the appropriate ... and maintaining GMP and USP compliance. In a new webinar from METTLER TOLEDO ... " these requirements are explained. The challenge is to determine how to ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the release of two biometric time and attendance tracking products: the new NCheck ... software. NCheck Cloud Bio Attendance uses biometric face recognition to enable users to ...
(Date:3/28/2017)... ... March 28, 2017 , ... In ... Self-Funding Success website has recently developed and published an informational resource that addresses ... created based on common inquiries the site’s team of third party administrator (TPA) ...
(Date:3/28/2017)... ... ... A minimally invasive porcelain veneer is increasing in popularity ... Dental Laboratories (NADL) is informing dentists about the benefits of minimally invasive dentistry, ... and technicians that create these veneers. , According to National Board for ...
(Date:3/28/2017)... ... ... Public relations pros work hard to earn placements and build a ... results are clear, much of PR is hard to quantify. Goal-setting and measurement are ... firms should always take an all-inclusive approach that takes both traditional and non-traditional factors ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)...  A new survey from the American ... Bidding Program (CBP) significantly reduced beneficiary choice and access ... choice forces beneficiaries to switch to unfamiliar or unsuitable ... AADE,s survey is the latest in a ... out the inherent problems with the CBP. Last year, ...
(Date:3/27/2017)... YORK , March 27, 2017 FinancialBuzz.com News ... According to a new ... North America , grew 34 percent to $6.7 billion and ... rate of (CAGR) over the next five years, from $6.7 billion in ... of Americans that will be able to purchase cannabis without a doctor,s ...
(Date:3/27/2017)... March 27, 2017   Pulmatrix, Inc . (NASDAQ: PULM), ... address serious pulmonary diseases, today announced that it has added ... fibrosis and asthma to its Scientific Advisory Board . ... Richard B. Moss , MD, former chief of the ... Cystic Fibrosis Center at Stanford University, and ...
Breaking Medicine Technology: